SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001773427-21-000025
Filing Date
2021-11-04
Accepted
2021-11-04 06:32:22
Documents
51
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q swtx-20210930.htm   iXBRL 10-Q 1372388
2 EX-31.1 swtx-20210930xex311.htm EX-31.1 11487
3 EX-31.2 swtx-20210930xex312.htm EX-31.2 11506
4 EX-32.1 swtx-20210930xex321.htm EX-32.1 5673
5 EX-32.2 swtx-20210930xex322.htm EX-32.2 5679
  Complete submission text file 0001773427-21-000025.txt   4319371

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT swtx-20210930.xsd EX-101.SCH 22035
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT swtx-20210930_cal.xml EX-101.CAL 48875
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT swtx-20210930_def.xml EX-101.DEF 82039
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT swtx-20210930_lab.xml EX-101.LAB 323434
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT swtx-20210930_pre.xml EX-101.PRE 194095
11 EXTRACTED XBRL INSTANCE DOCUMENT swtx-20210930_htm.xml XML 592001
Mailing Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902
Business Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902 203-883-9490
SpringWorks Therapeutics, Inc. (Filer) CIK: 0001773427 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39044 | Film No.: 211377860
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences